Multiple Co-primary Endpoints: Medical and Statistical Solutions A Report From the Multiple Endpoints Expert Team of the Pharmac
Multiple Co-primary Endpoints: Medical and Statistical Solutions A Report From the Multiple Endpoints Expert Team of the Pharmac
Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients with Oligometastatic Breast Cancer: Study protocol for a randomized controlled multi-national and multi-center clinical trial (OLIGOMA) - Clinical and Translational ...
The Regulatory Strategist Toolbox: Clinical Endpoint Analysis Tools | RAPS
Pfizer Shares Co-Primary Endpoint Results from Post-Marketing Required Safety Study of XELJANZ® (tofacitinib) in Subjects with Rheumatoid Arthritis (RA) | Business Wire
Composite End Points in Clinical Research | Circulation
5.3 Leveraging multiple endpoints in small clinical trials (Robin Ristl)
Design, data monitoring, and analysis of clinical trials with co-primary endpoints: A review: Journal of Biopharmaceutical Statistics: Vol 28, No 1
The Regulatory Strategist Toolbox: Clinical Endpoint Analysis Tools | RAPS
Multiplicity – What is it, and why is it important? - Quantics Biostatistics
Defining Endpoints and Biomarkers in Inflammatory Bowel Disease: Moving the Needle Through Clinical Trial Design - Gastroenterology
Clinical Data | XIAFLEX® (collagenase clostridium histolyticum)
PDF) A two-stage design with two co-primary endpoints
The Efficacy of XHANCE | XHANCE? (fluticasone propionate)
Sample size determination for a specific region in multiregional clinical trials with multiple co-primary endpoints | PLOS ONE
The ORVAC trial: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis: a statistical analysis
Clinical Trial Endpoints for Oncology Studies
On Biostatistics and Clinical Trials: November 2017
The Primary Outcome Fails — What Next? | NEJM
Multiple Co-primary Endpoints: Medical and Statistical Solutions A Report From the Multiple Endpoints Expert Team of the Pharmac
Choice of Primary (or Co-primary) Endpoints: Efficacy, Safety, or Net Clinical Benefit in Superiority and Non-inferiority Trials | tctmd.com
Choosing primary endpoints for clinical trials of health care interventions - ScienceDirect
